|
⚲
|
| Keyboard |
| Gosebruch Henry O
✚
|
|
|---|---|
| CIK # | 0001659625 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001659625] | |
| 4 | [0001659625] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Gosebruch Henry O | |
| Acelyrin Inc | |
| Neumora Therapeutics Inc | |
| Aptinyx Inc | |
| AbbVie Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Acelyrin Inc SLRN
Director Stock Option (right to buy) · derivative
|
2025-05-21 | Disposed to issuer | 92,158 | ||
|
Acelyrin Inc SLRN
Common Stock
|
2025-05-21 | Disposed to issuer | 50,000 | ||
|
Acelyrin Inc SLRN
Director Stock Option (right to buy) · derivative
|
2025-05-21 | Disposed to issuer | 155,450 | ||
|
Acelyrin Inc SLRN
Director Stock Option (right to buy) · derivative
|
2024-06-07 | Grant | 92,158 | $0.00 | |
|
Neumora Therapeutics Inc NMRA
Common Stock
|
2024-02-14 | Grant | 80,000 | $0.00 | |
|
Neumora Therapeutics Inc NMRA
Stock Option (Right to Buy) · derivative
|
2024-02-14 | Grant | 160,000 | $0.00 | |
|
Neumora Therapeutics Inc NMRA
Common Stock
|
2023-09-19 | Buy | 15,000 | $12.62 | 189,300 |
|
Acelyrin Inc SLRN
Common Stock
|
2023-05-09 | Buy | 50,000 | $18.00 | 900,000 |
|
Acelyrin Inc SLRN
Director Stock Option (right to buy) · derivative
|
2023-05-09 | Other | 155,450 | $0.00 | |
|
Acelyrin Inc SLRN
Director Stock Option (right to buy) · derivative
|
2023-05-09 | Other | 155,450 | $0.00 | |
|
Aptinyx Inc APTX
Stock Option (Right to Buy) · derivative
|
2022-05-26 | Grant | 40,000 | $0.00 | |
|
AbbVie Inc ABBV
Common Stock, $0.01 par value
|
2022-05-16 | Option exercise | 83,960 | $54.86 | 4,606,046 |
|
AbbVie Inc ABBV
Common Stock, $0.01 par value
|
2022-05-16 | Sell | 83,960 | $155.00 | 13,013,800 |
|
AbbVie Inc ABBV
Option (Right to Buy) · derivative
|
2022-05-16 | Option exercise | 83,960 | $54.86 | 4,606,046 |
|
AbbVie Inc ABBV
Common Stock, $0.01 par value
|
2022-03-01 | Sell | 5,167 | $147.60 | 762,649 |
|
AbbVie Inc ABBV
Common Stock, $0.01 par value
|
2022-03-01 | Sell | 15,733 | $146.81 | 2,309,762 |
|
AbbVie Inc ABBV
Common Stock, $0.01 par value
|
2022-03-01 | Sell | 4,000 | $148.71 | 594,840 |
|
AbbVie Inc ABBV
Common Stock, $0.01 par value
|
2022-03-01 | Sell | 100 | $149.38 | 14,938 |
|
AbbVie Inc ABBV
Common Stock, $0.01 par value
|
2022-03-01 | Sell | 5,596 | $147.54 | 825,634 |
|
AbbVie Inc ABBV
Common Stock, $0.01 par value
|
2022-03-01 | Sell | 8,303 | $148.62 | 1,233,992 |
| showing 20 of 120 most recent transactions | |||||